Clean Cost Of Revenue vs Research Development Analysis

CLEAN Stock

1,299 22.25 1.74%

Clean Science financial indicator trend analysis is way more than just evaluating Clean Science prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Clean Science is a good investment. Please check the relationship between Clean Science Cost Of Revenue and its Research Development accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clean Science and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Cost Of Revenue vs Research Development

Cost Of Revenue vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Clean Science Cost Of Revenue account and Research Development. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Clean Science's Cost Of Revenue and Research Development is -0.14. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Research Development in the same time period over historical financial statements of Clean Science and, assuming nothing else is changed. The correlation between historical values of Clean Science's Cost Of Revenue and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Clean Science and are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Cost Of Revenue i.e., Clean Science's Cost Of Revenue and Research Development go up and down completely randomly.

Correlation Coefficient

-0.14

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Clean Science income statement and represents the costs associated with goods and services Clean Science provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Research Development

Most indicators from Clean Science's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Clean Science current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clean Science and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of the 24th of November 2024, Selling General Administrative is likely to grow to about 511.9 M, while Tax Provision is likely to drop about 751.1 M.

	2021	2022	2023	2024 (projected)
Gross Profit	4.5B	6.1B	4.4B	3.8B
Total Revenue	6.8B	9.4B	7.9B	6.2B

Gross Profit Total Revenue

Clean Science fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets
Total Assets		0.42	0.76	0.97	1.0	0.96	0.98	0.89	0.56	0.28	1.0	0.96	-0.25	0.89	-0.17	0.83	0.96	0.98	0.22	0.57	0.99	0.99	0.86	-0.93	0.98	0.99
Short Long Term Debt Total	0.42		0.59	0.35	0.43	0.33	0.35	0.44	-0.05	0.74	0.43	0.23	-0.71	0.43	0.18	0.19	0.38	0.43	0.19	0.21	0.41	0.38	0.37	-0.39	0.36	0.39
Other Current Liab	0.76	0.59		0.82	0.75	0.7	0.75	0.7	0.12	0.63	0.75	0.69	-0.61	0.7	-0.5	0.8	0.79	0.75	0.25	0.5	0.72	0.66	0.58	-0.66	0.81	0.76
Total Current Liabilities	0.97	0.35	0.82		0.96	0.95	0.98	0.85	0.55	0.21	0.96	0.98	-0.18	0.85	-0.27	0.88	0.97	0.98	0.24	0.59	0.93	0.93	0.83	-0.83	1.0	0.98
Total Stockholder Equity	1.0	0.43	0.75	0.96		0.96	0.98	0.89	0.56	0.29	1.0	0.95	-0.26	0.89	-0.16	0.82	0.96	0.97	0.22	0.56	0.99	0.99	0.86	-0.93	0.97	0.98
Other Liab	0.96	0.33	0.7	0.95	0.96		0.98	0.81	0.6	0.21	0.96	0.95	-0.18	0.81	-0.27	0.89	0.95	0.96	0.14	0.62	0.97	0.95	0.79	-0.87	0.96	0.97
Net Tangible Assets	0.98	0.35	0.75	0.98	0.98	0.98		0.8	0.65	0.18	0.98	0.98	-0.16	0.8	-0.23	0.87	0.98	0.98	0.11	0.67	0.95	0.96	0.78	-0.87	0.98	0.99
Property Plant And Equipment Net	0.89	0.44	0.7	0.85	0.89	0.81	0.8		0.32	0.39	0.89	0.84	-0.32	1.0	-0.11	0.68	0.83	0.86	0.62	0.28	0.9	0.88	0.98	-0.86	0.87	0.86
Current Deferred Revenue	0.56	-0.05	0.12	0.55	0.56	0.6	0.65	0.32		-0.41	0.56	0.65	0.43	0.33	0.14	0.46	0.65	0.65	-0.08	0.76	0.49	0.6	0.39	-0.53	0.55	0.65
Net Debt	0.28	0.74	0.63	0.21	0.29	0.21	0.18	0.39	-0.41		0.29	0.05	-0.99	0.39	-0.35	0.31	0.26	0.2	0.27	0.1	0.32	0.21	0.22	-0.4	0.23	0.23
Retained Earnings	1.0	0.43	0.75	0.96	1.0	0.96	0.98	0.89	0.56	0.29		0.96	-0.26	0.89	-0.16	0.82	0.96	0.97	0.21	0.56	0.99	0.99	0.86	-0.93	0.97	0.98
Accounts Payable	0.96	0.23	0.69	0.98	0.95	0.95	0.98	0.84	0.65	0.05	0.96		-0.02	0.84	-0.19	0.83	0.95	0.97	0.21	0.56	0.93	0.95	0.84	-0.83	0.98	0.97
Cash	-0.25	-0.71	-0.61	-0.18	-0.26	-0.18	-0.16	-0.32	0.43	-0.99	-0.26	-0.02		-0.32	0.38	-0.3	-0.23	-0.16	-0.17	-0.11	-0.29	-0.18	-0.14	0.37	-0.2	-0.2
Non Current Assets Total	0.89	0.43	0.7	0.85	0.89	0.81	0.8	1.0	0.33	0.39	0.89	0.84	-0.32		-0.12	0.68	0.83	0.86	0.62	0.29	0.9	0.89	0.98	-0.87	0.87	0.86
Non Currrent Assets Other	-0.17	0.18	-0.5	-0.27	-0.16	-0.27	-0.23	-0.11	0.14	-0.35	-0.16	-0.19	0.38	-0.12		-0.66	-0.31	-0.14	-0.03	-0.35	-0.19	-0.07	0.05	0.2	-0.26	-0.21
Other Assets	0.83	0.19	0.8	0.88	0.82	0.89	0.87	0.68	0.46	0.31	0.82	0.83	-0.3	0.68	-0.66		0.91	0.83	0.15	0.72	0.81	0.76	0.58	-0.77	0.87	0.87
Cash And Short Term Investments	0.96	0.38	0.79	0.97	0.96	0.95	0.98	0.83	0.65	0.26	0.96	0.95	-0.23	0.83	-0.31	0.91		0.97	0.23	0.74	0.92	0.93	0.78	-0.9	0.97	0.99
Net Receivables	0.98	0.43	0.75	0.98	0.97	0.96	0.98	0.86	0.65	0.2	0.97	0.97	-0.16	0.86	-0.14	0.83	0.97		0.25	0.63	0.95	0.96	0.85	-0.86	0.98	0.99
Common Stock Shares Outstanding	0.22	0.19	0.25	0.24	0.22	0.14	0.11	0.62	-0.08	0.27	0.21	0.21	-0.17	0.62	-0.03	0.15	0.23	0.25		-0.14	0.23	0.21	0.61	-0.29	0.24	0.23
Short Term Investments	0.57	0.21	0.5	0.59	0.56	0.62	0.67	0.28	0.76	0.1	0.56	0.56	-0.11	0.29	-0.35	0.72	0.74	0.63	-0.14		0.48	0.52	0.21	-0.6	0.58	0.67
Non Current Liabilities Total	0.99	0.41	0.72	0.93	0.99	0.97	0.95	0.9	0.49	0.32	0.99	0.93	-0.29	0.9	-0.19	0.81	0.92	0.95	0.23	0.48		0.98	0.87	-0.92	0.95	0.96
Inventory	0.99	0.38	0.66	0.93	0.99	0.95	0.96	0.88	0.6	0.21	0.99	0.95	-0.18	0.89	-0.07	0.76	0.93	0.96	0.21	0.52	0.98		0.88	-0.93	0.95	0.97
Other Current Assets	0.86	0.37	0.58	0.83	0.86	0.79	0.78	0.98	0.39	0.22	0.86	0.84	-0.14	0.98	0.05	0.58	0.78	0.85	0.61	0.21	0.87	0.88		-0.8	0.84	0.83
Other Stockholder Equity	-0.93	-0.39	-0.66	-0.83	-0.93	-0.87	-0.87	-0.86	-0.53	-0.4	-0.93	-0.83	0.37	-0.87	0.2	-0.77	-0.9	-0.86	-0.29	-0.6	-0.92	-0.93	-0.8		-0.85	-0.91
Total Liab	0.98	0.36	0.81	1.0	0.97	0.96	0.98	0.87	0.55	0.23	0.97	0.98	-0.2	0.87	-0.26	0.87	0.97	0.98	0.24	0.58	0.95	0.95	0.84	-0.85		0.98
Total Current Assets	0.99	0.39	0.76	0.98	0.98	0.97	0.99	0.86	0.65	0.23	0.98	0.97	-0.2	0.86	-0.21	0.87	0.99	0.99	0.23	0.67	0.96	0.97	0.83	-0.91	0.98

Click cells to compare fundamentals

Clean Science Account Relationship Matchups

Clean Science fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.3B	6.6B	9.2B	11.5B	14.0B	8.1B
Short Long Term Debt Total	26.0M	26.9M	3.3M	20.6M	20.3M	16.6M
Other Current Liab	412.7M	409.9M	221.8M	288.0M	448.0M	326.2M
Total Current Liabilities	769.6M	1.0B	1.3B	1.2B	1.6B	1.1B
Total Stockholder Equity	3.4B	5.4B	7.7B	10.1B	12.0B	6.8B
Other Liab	141.8M	105.4M	179.4M	210.5M	242.1M	163.0M
Net Tangible Assets	2.7B	3.4B	5.4B	7.7B	8.8B	4.6B
Property Plant And Equipment Net	1.7B	2.5B	3.4B	4.8B	7.0B	7.3B
Current Deferred Revenue	(24.0M)	10.4M	326.3M	267.3M	7.3M	6.9M
Net Debt	(65.2M)	(90.1M)	(575.7M)	(104.1M)	(84.2M)	(88.4M)
Retained Earnings	3.3B	5.2B	7.5B	9.9B	11.8B	6.6B
Accounts Payable	356.9M	609.9M	1.0B	805.1M	1.1B	685.9M
Cash	92.1M	93.4M	579.0M	124.7M	104.5M	158.0M
Non Current Assets Total	1.7B	2.6B	3.5B	5.2B	7.4B	7.7B
Non Currrent Assets Other	10K	(2.4B)	105.7M	124.9M	(220.1M)	(231.1M)
Other Assets	36.9M	35.3M	239.4M	144.9M	166.6M	100.4M
Cash And Short Term Investments	1.4B	2.5B	3.0B	3.4B	3.1B	2.3B
Net Receivables	796.7M	939.3M	1.5B	1.5B	1.6B	1.2B
Short Term Investments	1.3B	2.4B	2.4B	3.3B	278.7M	264.8M
Liabilities And Stockholders Equity	4.3B	6.6B	9.2B	11.5B	14.0B	8.1B
Non Current Liabilities Total	108.2M	182.7M	213.2M	263.2M	331.1M	211.6M
Inventory	345.9M	529.0M	881.3M	1.1B	1.3B	752.3M
Total Liab	877.8M	1.2B	1.6B	1.4B	1.9B	1.3B
Total Current Assets	2.6B	4.0B	5.7B	6.3B	6.6B	4.4B
Accumulated Other Comprehensive Income	60.1M	43.0M	47.8M	55.6M	66.7M	47.7M
Short Term Debt	24.0M	10.4M	(6.2M)	2M	1.6M	1.5M
Intangible Assets	2.5M	2.7M	4.7M	6.0M	7.4M	4.4M
Property Plant Equipment	1.3B	1.7B	2.4B	3.4B	3.9B	2.2B
Net Invested Capital	3.4B	5.4B	7.7B	10.1B	12.0B	7.6B
Net Working Capital	1.8B	2.9B	4.4B	5.1B	5.0B	3.8B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Other Information on Investing in Clean Stock

Balance Sheet is a snapshot of the financial position of Clean Science at a specified time, usually calculated after every quarter, six months, or one year. Clean Science Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Clean Science and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Clean currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Clean Cost Of Revenue vs Research Development Analysis

Cost Of Revenue vs Research Development

Cost Of Revenue vs Research Development Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Research Development

Clean Science fundamental ratios Correlations

Clean Science Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Clean Science fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Clean Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Retained Earnings	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Non Current Liabilities Total	+ 0.99	Total Assets

Cash	- 0.99	Net Debt
Other Stockholder Equity	- 0.93	Inventory
Other Stockholder Equity	- 0.93	Retained Earnings
Other Stockholder Equity	- 0.93	Total Stockholder Equity
Other Stockholder Equity	- 0.93	Total Assets
Other Stockholder Equity	- 0.92	Non Current Liabilities Total